Related Experiment Videos
Suicide risk not increased with SSRI antidepressants
1Department of Virginia Family Medicine, Charlottesville, USA. ph2t@virginia.edu
The Journal of Family Practice
|August 6, 2003
Summary
Adults with mild to moderate depression taking selective serotonin reuptake inhibitors (SSRIs) are not more likely to commit suicide than those on other antidepressants, including tricyclic antidepressants (TCAs). This suggests a reassessment of antidepressant prescribing practices is warranted.
Area of Science:
- Psychiatry
- Clinical Psychology
- Pharmacology
Background:
- Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed for depression.
- Concerns persist regarding the suicide risk associated with SSRIs compared to other antidepressant classes.
- Tricyclic antidepressants (TCAs) are an older class of antidepressants often avoided due to perceived risks.
Discussion:
- This study analyzed suicide rates in depressed adult patients across different antidepressant classes.
- Findings indicate no statistically significant difference in suicide risk between SSRIs and other antidepressants, including TCAs.
- The perceived higher risk of TCAs compared to other antidepressants is not supported by this data.
Key Insights:
- Adult patients with mild to moderate depression do not exhibit a higher suicide risk when treated with SSRIs versus other antidepressants.
- The suicide rate in the non-SSRI group, which included TCAs, was low, challenging the notion that TCAs are inherently more dangerous.
- Clinicians may reconsider avoiding all antidepressants due to suicide risk concerns.
Outlook:
- These findings may encourage broader antidepressant prescribing for eligible patients.
- Further research could explore long-term outcomes and specific patient subgroups.
- The study highlights the importance of evidence-based practice in psychopharmacology.